SFX, which was originally an antibacterial drug, has been shown to inhibit components within or related to the ESCRT-dependent pathway, including ALIX and VPS4B, as well as some RAB proteins in breast cancer cell lines95,100. The gene discussed is PDCD6IP; the disease is breast cancer.